Cellular and T cell engager Immunotherapy
Combined GPRC5D and BCMA-targeted T-cell redirecting therapy in the treatment of RRMM
Kelly N. Godby, MD (she/her/hers)
Associate Professor of Medicine
University of Alabama Birmingham
Birmingham, Alabama, United States